VAXCYTE INC (PCVX) Stock Income Statement
NASDAQ:PCVX - Nasdaq - US92243G1085 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 636.00M | 570.00M | 393.00M | 209.26M | 103.67M | |||
| Research and Development | N/A | 476.64M | 332.34M | 135.68M | 60.94M | |||
| Selling, General, and Administrative Expenses | 106.00M | 93.00M | 61.00M | 73.59M | 42.74M | |||
| Operating Income | -636.00M | -570.00M | -393.00M | -209.26M | -103.67M | |||
| Interest Income/Expense | N/A | 109.99M | 61.01M | 6.88M | 2.01M | |||
| Other Income/Expense | 29.68M | -4.38M | 4.77M | 1.93M | 1.59M | |||
| Non Recurring Items | N/A | 0.00 | -75.00M | -23.04M | N/A | |||
| Income Before Taxes | -510.00M | -464.00M | -402.00M | -223.49M | -100.08M | |||
| Net Income | -510.00M | -464.00M | -402.00M | -223.49M | -100.08M | |||
| EBITDA | -627.04M | -563.00M | -389.84M | -206.68M | -101.87M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.98 | -3.80 | -4.14 | -3.44 | -1.93 | |||
| Non GAAP EPS | -3.98 | -3.79 | -4.13 | -3.43 | -1.93 | |||
| Statistics | ||||||||
All data in USD